Trusted by Top 10 pharmas, QuartzBio Sample Intelligence is the upstream data foundation that gives translational leaders confidence in every readout. It eliminates data fragmentation to improve sample usability, and enable faster, higher‑confidence portfolio decisions.
Schedule a 15-min executive walkthrough to see the impact for your trials.
Translational executives are accountable for pipeline outcomes—but upstream data fragmentation creates hidden operational drag:
The science may be sound, but the data infrastructure isn’t. Budgets get drained. Programs are cut.
Unlike traditional LIMS or data integration tools, Sample Intelligence identifies and resolves data quality issues before they impact analysis. Every data point is complete, traceable, and validated—so your team can defend what they report.
Stop reacting to downstream data issues. Start enabling faster, better decisions upstream.
“With QuartzBio, we spend 85% less time on sample-related tasks.”
–Top Biopharma
A Top 5 pharma discovered that outdated sample ops workflows were putting their pipeline at risk. With QuartzBio, they addressed fragmented data, manual workflows, and lack of visibility across the sample lifecycle, achieving:
In just 15 minutes, identify the hidden data bottlenecks slowing your trials and quantify the impact of unified sample data on your pipeline.
QuartzBio is the only company purpose-built to deliver end-to-end Sample and Biomarker Intelligence for clinical-stage biopharma teams. Powered by a network of domain-specific AI agents, our solutions transform fragmented data into actionable intelligence, enabling conversational insights into your unified ecosystem of sample, clinical, and biomarker data.
QUARTZBIO® is a registered trademark of Precision Regulatory and Translational Sciences, Inc., dba QuartzBio, in the United States and/or other jurisdictions. All rights reserved.
© 2026 QuartzBio.
All rights reserved.
Privacy Notice
Ethics & Third-Party Notice
